한글목차

세계의 컴퓨터 보조 검출 시장 미래는 결핵, 유방암, 폐암, 결장암, 전립선암, 간암, 골암, 신경, 근골격계 및 심혈관계의 적응증 시장에 있어서의 기회로 유망시되고 있습니다. 세계의 컴퓨터 보조 검출 시장은 2025년부터 2031년까지의 CAGR이 10.2%를나타낼 전망이며, 2031년까지 15억 달러에 이를 것으로 예상됩니다. 이 시장의 주요 촉진요인은 정기적인 건강 진단에 대한 인식 증가, 지속적인 기술의 진보, 만성 질환의 유병률 증가입니다.

• Lucintel사의 예측에 의하면, 적응증별로는 암의 이환율 증가에 의해 X선 화상 진단이 예측 기간 중에서 가장 높은 성장을 이룰 전망입니다.
• 용도별로는 유방암 이환율의 상승, 유방암 검진의 조기 발견에 대한 의식과 대처의 고조에 의해 유방암이 계속해서 최대 부문을 차지할 것입니다.
• 지역별로는 암 진단을 위한 컴퓨터 보조 검출의 채택이 증가하고 있고, 의료 지출이 증가하고 있기 때문에 북미가 최대 지역으로 계속 남을 것입니다.

컴퓨터 보조 검출 시장의 전략적 성장 기회

컴퓨터 지원 감지(CAD) 시장에서는 다양한 용도와 관련하여 다양한 전략적 성장 기회가 탄생했습니다. 이러한 기회는 기술적 개선과 의료 요구의 변화로 인해 발생합니다.

• 조기 암 검출 : CAD 시스템은 조기 암 검출에의 응용이 진행되고 있어 종양학 용도의 성장을 견인하고 있습니다. 화상처리와 AI기술의 개발에 의해 암의 조기 발견이 향상되어 치료의 강화로 이어집니다. 이 용도는 인구의 통계적인 암 환자 증가와 조기 진단의 필요성 때문에 성장의 주요 관심 분야가 되고 있습니다.
• 심혈관 질환 모니터링 : CAD 시스템 시장 기회를 제공하는 또 다른 분야는 심혈관 질환 환자를 모니터링하는 것입니다. 기술의 새로운 동향과 인공지능의 응용은 심장과 혈관의 병태를 확인하는 능력을 향상시킵니다. 이 애플리케이션은 심혈관 질환에 대한 개입을 촉진하고 예방 의학의 현재 의제와 일치하기 때문에 시장에서 큰 성장 가능성을 가지고 있습니다.
• 방사선 워크플로우 강화 : CAD 시스템의 지원으로 이미지 처리 및 보고 생성의 기술적 능력으로 방사선과 워크플로우가 보다 효율적으로 되었습니다. 기존 이미징 장치와의 호환성으로 이러한 시스템은 이미징 워크플로에 연결되어 진단 속도를 높일 수 있습니다. 이 용도는 방사선 진단 방법의 간소화에 대한 요구 증가에 대응하고 임상 실천을 강화함으로써 시장을 확대합니다.
• 원격 거주자의 진단 서비스 : 원격 의료 및 원격 진단 서비스의 출현으로 클라우드 기반 비교 지원 설계 시장도 성장하고 있습니다. 이러한 시스템은 의료 서비스가 없는 지역의 환자가 진단 도구 및 정보에 액세스하는 데 도움이 됩니다. 통신 진단 및 화면 진단을 포함한 원격 의료 조치의 성장은 이 개발을 지원하는 데 필요한 CAD 시스템의 유형에 영향을 미칩니다.
• 맞춤형 의료 서비스 : 개인화된 의료 서비스 개발에 CAD를 사용하여 발견과 치료 옵션을 늘리는 것이 일반적입니다. 개별 환자의 병력 및 이미지 데이터와 같은 데이터를 활용함으로써 CAD 시스템은 보다 향상된 맞춤형 의료 서비스를 제공합니다. 의료의 중심이 개인화된 의료로 이동함에 따라, 이 용도는 더욱 중요해지고 CAD 기술 제공업체에게 더 많은 기회가 열릴 것으로 예상됩니다.

이 섹션에서 강조된 전략적 성장 전망은 임상 현장에서 CAD 시스템의 중요성이 증가하고 있음을 보여줍니다. 이것은 주로 암 검진, 심혈관 평가, 워크플로우 개선, 원격 의료, 개인화 치료에 의해 달성되기 때문에 CAD 시장의 번영이 기대됩니다. 이러한 성장 기회는 차세대 진단에 대한 수요 증가와 전체 의료 포트폴리오와의 통합 가능성을 보여줍니다.

컴퓨터 보조 검출 시장 성장 촉진요인 및 과제

컴퓨터 보조 검출(CAD) 시장은 기술적 변화, 경제적 결정 요인, 법규제 요인 등 많은 촉진요인과 과제의 영향을 계속 받고 있습니다. 이 모든 측면은 시장의 복잡성을 이해하는 데 중요합니다.

컴퓨터 보조 검출 시장 성장 촉진요인은 다음과 같습니다.

• 기술 진보: CAD 시장은 AI, ML, 화상 처리 기술의 발전으로 활성화되고 있습니다. 이러한 기술은 CAD 시스템의 사용 정확도와 속도를 향상시킵니다. 신기술은 기존 시스템을 개선하고 새로운 잠재력을 창출함으로써 시장 성장을 가속합니다.
• 의료 투자 증가 : 의료 투자 증가가 CAD 시장에 박차를 가하고 있습니다. 정부기관과 민간단체 모두 CAD기술의 창조와 기존 시스템에의 통합을 포함한 보다 진보된 진단기기와 툴의 도입을 추진하고 있습니다. 이 투자 동향은 시장 확대를 촉진하고 CAD 솔루션의 범위를 확대하고 있습니다.
• 질병 관리에 대한 지속적인 영향의 중요성 : 질병의 조기 발견이 중요시되고 CAD 시스템에 대한 수요가 증가하고 있습니다. CAD 관련 기술은 주로 조기 진단과 리스크 평가를 목적으로 하고 있으며, 예방 의료에 합치하고 있습니다. 이러한 요구 증가는 의료 시스템이 실용적이고 효율적인 진단 도구를 찾고 있기 때문에 CAD 업계의 확대를 뒷받침하고 있습니다.
• 규제 당국의 승인 및 지원 : 신규 CAD 개발에 대한 규제 당국의 허가 및 시장 개척 지원이 시장 성장을 가능하게 합니다. 새로운 용도와 시스템이 규제 당국에 의해 승인되고 CAD 전망이 재구성되고 있습니다. 이에 따라 신기술의 성장에 유리한 환경이 생겨 그 목적이 달성되는 것이 확인되었습니다.
• 더 넓은 시장으로가는 길 : CAD 시스템의 새로운 시장으로의 침투로 CAD 시장이 성장하고 있습니다. 의료에 대한 수요가 증가하고 이러한 분야에 투자함으로써 CAD 도입은 유리한 상황이되었습니다. 신흥 시장은 저렴한 솔루션과 정부의 이니셔티브으로 시장 진입과 성장을 지원하고 CAD 기술의 도달범위를 넓혀가고 있습니다.

컴퓨터 보조 검출 시장의 과제는 다음과 같습니다.

• 첨단 기술 비용 고 : 고가의 고급 CAD 기술은 비용이 중요한 요소인 특정 시장으로의 도입을 제한합니다. 시스템 및 배포 가격이 높기 때문에 예상되는 서비스의 사용이 제한될 수 있으며 시장의 보편적 가치를 달성하는 데 어려움이 있습니다.
• 데이터의 프라이버시와 보안에 대한 우려 : 시장 분석에 따르면 예상되는 프라이버시 침해는 CAD 시스템의 성장을 위협할 위험이 있습니다. 많은 환자들은 안전이 보장되고 관련 정책이 정비될 때까지 이러한 시스템의 사용을 망설일 수 있습니다.
• 기존 시스템과의 통합 : CAD 시스템이 도입되면 다음에 필요한 것은 기존의 의료처럼 IT 시스템이나 이미징 모달리티와의 통합입니다. 상호 운용성과 시스템 업데이트의 필요성은 CAD 기술의 도입을 복잡하게 하여 시장 성장을 방해할 수 있습니다.

CAD 시장의 주요 촉진요인 및 과제는 업계의 유동성을 이야기하고 있습니다. 신기술, 의료 투자, 법적 뒷받침이 시장을 확대하는 한편, 고비용, 프라이버시에 대한 우려, 부적절한 통합이 성능을 방해하고 있습니다. 이러한 과제를 극복하고 성장 촉진요인을 활용하는 것이 향후 몇 년간의 CAD 시장 개척에 큰 영향을 줄 것으로 보입니다.

목차

제1장 주요 요약

제2장 세계의 컴퓨터 보조 검출 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 컴퓨터 보조 검출 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 컴퓨터 보조 검출 시장 : 적응증별
  • X선 영상
  • 컴퓨터 단층 촬영
  • 초음파 영상 진단
  • 자기 공명
  • 핵의학 영상 진단
• 세계의 컴퓨터 보조 검출 시장 : 용도별
  • 결핵
  • 유방암
  • 폐암
  • 대장암
  • 전립선암
  • 간암
  • 뼈암
  • 신경계, 근골격계, 심혈관계의 적응증

제4장 지역별 시장 동향과 예측 분석(2019-2031년)

• 세계의 컴퓨터 보조 검출 시장 : 지역별
• 북미의 컴퓨터 보조 검출 시장
• 유럽의 컴퓨터 보조 검출 시장
• 아시아태평양의 컴퓨터 보조 검출 시장
• 기타 지역의 컴퓨터 보조 검출 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 컴퓨터 보조 검출 시장의 성장 기회 : 적응증별
  • 세계의 컴퓨터 보조 검출 시장의 성장 기회 : 용도별
  • 세계의 컴퓨터 보조 검출 시장의 성장 기회 : 지역별
• 세계의 컴퓨터 보조 검출 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 컴퓨터 보조 검출 시장의 생산 능력 확대
  • 세계의 컴퓨터 보조 검출 시장에 있어서의 기업 합병 및 인수(M&A), 합작 사업
  • 인증 및 라이선싱

제7장 주요 기업 프로파일

• EDDA Technology
• FUJIFILM Holdings Corporation
• Hologic
• Koninklijke Philips
• Siemens
• Nano-X Imaging
• Canon Medical Systems
• General Electric
• IBM
• Riverain Technologies

영문목차

The future of the global computer aided detection market looks promising with opportunities in the tuberculosis, breast cancer, lung cancer, colon cancer, prostate cancer, liver cancer, bone cancer, and neurological/musculoskeletal/cardiovascular indications markets. The global computer aided detection market is expected to reach an estimated $1.5 billion by 2031 with a CAGR of 10.2% from 2025 to 2031. The major drivers for this market are the growing awareness of regular health checks, ongoing technological advancements, and the increasing prevalence of chronic diseases.

• Lucintel forecasts that, within the indication category, X-ray imaging is expected to witness the highest growth over the forecast period due to the growing incidence of cancer.
• Within the application category, breast cancer will remain the largest segment due to the rising incidence rate of breast cancer and growing awareness & initiatives towards early detection of breast cancer screening.
• In terms of region, North America will remain the largest region due to the growing adoption of computer aided detection for cancer diagnosis and increasing healthcare spending in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Computer Aided Detection Market

On the rise, there are many emerging trends that are changing the dynamics of the computer-aided detection (CAD) market. The trends are indicative of technological development as well as changing expectations in the healthcare sector, improving diagnostic processes.

• AI and Machine Learning Integration: AI and machine learning-based models are becoming increasingly embedded in CAD systems, helping to extend the capacity of the model to process complicated imaging outcomes and improve its diagnostic components. Such features allow CAD systems to be developed through training with abundant information, making abnormality detection accurate, thus enhancing healthcare. Ruinously, the capacity of AI algorithms will continue growing; therefore, a bigger vision of their implementation will be shown in CAD applications.
• Expansion into Emerging Markets: The CAD market is entering new markets that are emerging and have an increased appetite for advanced diagnostic instruments. In regions like Asia-Pacific and Latin America, there has been increased healthcare expenditure and government initiatives; therefore, such growth is taking place. Emerging markets are subscribing to cheaper CAD solutions in an effort to meet the increased demand for healthcare services and enhance early disease diagnosis.
• The New Generation of Imaging Technologies: The introduction of imaging technologies such as high-resolution MRI and CT scans is helping to improve CAD systems. These developments enhance the interpretation of medical images and improve the accuracy and precision of disease diagnosis. One of the leading trends in increasing diagnostic efficacy is the combination of existing CAD systems with new imaging technologies.
• Web-Based CAD Solutions: Cloud-based CAD solutions are becoming more accepted because of their flexibility and scalability. They allow for remote access to diagnostic equipment and storage of data, enabling healthcare workers to share information and collaborate, thus assisting in the diagnostic process. Cloud-based CAD systems also offer live updates and the incorporation of other healthcare services to optimize operations.
• Emphasis on Preventative Healthcare: There is an increasing emphasis on preventative healthcare, and CAD systems assume an important role in this regard by assisting in the screening of diseases and evaluating risks. By diagnosing health problems before they worsen, CAD systems aid in preventive healthcare, thus minimizing the cost of care. This direction is forcing the creation of newer, more efficient, and simpler-to-use CAD instruments.

As these trends create space in the diagnostic markets and increase detection capabilities, market scope is enhanced for the treatment of CAD. Innovation is fueled by the introduction of AI, cloud-based systems, and imaging technologies, while the trend of prevention influences what CAD will look like in the future. These trends are together facilitating enhanced diagnosis as well as care for patients.

Recent Developments in the Computer Aided Detection Market

The recent developments in the computer-aided detection (CAD) market can be attributed to technological evolution, regulatory reforms, and clients' need for more healthcare services. These developments are improving diagnostics and enhancing market coverage.

• AI-Powered Diagnostic Tools: The incorporation of artificial intelligence within CAD systems has significantly improved the accuracy of disease diagnosis. AI algorithms can process image data more quickly by providing more sophisticated scrutiny, aiding in earlier and more accurate disease diagnoses. Such developments boost the efficacy of CAD systems and enhance the quality of care across many healthcare facilities.
• Improvements in Imaging Techniques: High-resolution MRI and CT scans in modern imaging technologies are enhancing the functionalities of CAD systems. Improved imaging adds additional analytical data for more accurate disease diagnosis. This trend is aiding the development of CAD systems and their incorporation into medical practice.
• Most Regulatory Approvals: Recently, regulatory bodies have been issuing more approvals for new CAD applications and technologies, thus increasing their availability in the market. Recent approvals include advanced software solutions and imaging techniques. Such support enhances the acceptance of CAD systems and boosts market growth through the approval of new technologies and their use.
• Pulse in Emerging Markets: There is also a surfacing trend of increasing CAD adoption in emerging markets due to increased healthcare budgets and the need for better diagnostic equipment. More affordable CAD practices are being employed in response to local healthcare needs, while market growth is aided by government initiatives. This trend enhances the penetration of CAD technologies and improves the standard of living in these areas.
• Cooperation with Healthcare Providers: There is a rising trend of closer ties between CAD technology providers and healthcare establishments. As a result, innovation and integration of systems improve. The alliances facilitate the creation of bespoke solutions and augment the CAD system installation process into clinical workflows. This shift positively impacts the expansion of the CAD industry and increases diagnostic capabilities.

The increasing scope of technological improvement, the rising number of regulatory approvals, and the growing acceptance of CAD in emerging markets are factors boosting the CAD industry. Engagement with healthcare providers and improvements in imaging technologies are also contributing to growth and enhancing the quality of diagnostics, shaping the outlook of the CAD industry.

Strategic Growth Opportunities for Computer Aided Detection Market

Various strategic growth opportunities are emerging with respect to different applications in the computer-aided detection (CAD) market. These opportunities arise from technological improvements and changing healthcare needs.

• Early Cancer Detection: CAD systems are increasingly applied in early cancer detection, driving growth in oncology applications. Imaging and AI technology development improve the positive detection of cancer early, assisting in the enhancement of treatment. This application is a major area of interest for growth due to the statistical increase in cancer cases among the population and the need for early-stage diagnosis.
• Cardiovascular Disease Monitoring: Another area presenting a market opportunity for CAD systems is monitoring patients for cardiovascular disease. Emerging trends in technology and the application of artificial intelligence are improving the ability to identify cardiac and vascular pathologies. This application facilitates interventions for cardiovascular disease and aligns with the current agenda of preventive medicine, which holds significant growth potential in the market.
• Enhancements to Radiology Workflow: With the help of CAD systems, workflows in radiology are becoming more efficient due to the technological capacity to process images and generate reports. Compatibility with existing imaging devices connects these systems to imaging workflows, speeding up diagnosis. This application responds to the increasing need for simplicity in radiology methods and enhances clinical practices, thereby expanding the market.
• Diagnostic Services by Remote Residents: With the emergence of telehealth and remote diagnostic services, there is also growth in the market for cloud-based Comparative Aid Design. These systems help patients in areas without medical services access diagnostic tools and information. The growth in telehealth measures, including communicable and on-screen diagnostics, is influencing the types of CAD systems needed to support this development.
• Customized Medical Services: It has become common practice to use CAD in the development of personalized medicine services, enhancing detection and treatment options. By utilizing data such as individual patients' medical histories and imaging data, CAD systems offer improved and individualized healthcare services. As the focus of medicine shifts towards personalized care, this application is expected to gain more significance, opening further opportunities for CAD technology providers.

Strategic growth prospects highlighted in these sections show the growing significance of CAD systems in clinical settings. This will primarily be achieved through cancer screening, cardiovascular assessment, workflow improvements, telemedicine, and customized therapy, so the CAD market is expected to thrive. These growth opportunities indicate the increasing demand for new-generation diagnostics and possible integrations with the overall healthcare portfolio.

Computer Aided Detection Market Driver and Challenges

The computer-aided detection (CAD) market remains affected by a host of drivers and challenges, including technological change, economic determinants, and legislative factors. All these aspects are important in understanding the complexities of the market.

The factors driving the computer-aided detection market include:

• Technological Advancements: The CAD market is boosted by advancements in AI, ML, and imaging technologies. These technologies increase the precision and speed with which CAD systems are utilized. New technologies improve existing systems and create new possibilities that fuel market growth.
• Increasing Healthcare Investments: Increased healthcare investment is spurring the CAD market. Both government and private entities are implementing more sophisticated diagnostic equipment and tools, including the creation and integration of CAD technologies into existing systems. This trend of investment facilitates market expansion and widens the scope of CAD solutions.
• Emphasis on Sustained Impact on Disease Management: The growing importance placed on early disease detection is driving demand for CAD systems. Technologies related to CAD primarily serve the purpose of early diagnosis and risk evaluation, aligning with preventive healthcare. This increased need is aiding the expansion of the CAD industry as healthcare systems seek practical and efficient diagnostic tools.
• Regulatory Approvals and Support: Permissions issued by regulatory authorities and market support for novel CAD developments are enabling market growth. New applications and systems are being approved by regulators, reshaping the CAD landscape. This creates a favorable environment for the growth of new technologies, confirming that their objectives are met.
• Wider Market Avenues: The CAD market has grown due to the penetration of CAD systems into new markets. Conditions are favoring CAD adoption due to growing healthcare demands and investments in these areas. Emerging markets support market entry and growth due to affordable solutions and government efforts, thus extending the reach of CAD technologies.

Challenges in the computer-aided detection market include:

• High Costs of Advanced Technologies: The expensive advanced CAD technologies limit their incorporation in certain markets where cost is a significant factor. High prices for systems and deployment may restrict the usage of anticipated services, posing challenges in achieving universal value for the market.
• Data Privacy and Security Concerns: Market analysis shows that anticipated privacy violations pose risks threatening the growth of CAD systems. Many patients may hesitate to engage with these systems until their safety is assured and relevant policies are in place.
• Integration with Existing Systems: Once a CAD system is in place, the next requirement is to integrate it with the existing healthcare IT system and imaging modalities. Interoperability and the need to update systems can complicate the embrace of CAD technologies, impeding market growth.

The CAD market key drivers and challenges illustrate the industry's fluidity. Emerging technologies, healthcare investments, and legal backing are expanding the market, while high costs, privacy concerns, and inadequate integration hinder performance. Meeting these challenges and leveraging growth drivers will significantly impact the development of the CAD market in the coming years.

List of Computer Aided Detection Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies computer aided detection companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the computer aided detection companies profiled in this report include-

• Edda Technology
• Fujifilm Holdings Corporation
• Hologic
• Koninklijke Philips
• Siemens
• Nano-X Imaging
• Canon Medical Systems
• General Electric
• IBM
• Riverain Technologies

Computer Aided Detection by Segment

The study includes a forecast for the global computer aided detection market by indication, application, and region.

Computer Aided Detection Market by Indication [Analysis by Value from 2019 to 2031]:

• X-Ray Imaging
• Computed Tomography
• Ultrasound Imaging
• Magnetic Resonance
• Nuclear Medicine Imaging

Computer Aided Detection Market by Application [Analysis by Value from 2019 to 2031]:

• Tuberculosis
• Breast Cancer
• Lung Cancer
• Colon Cancer
• Prostate Cancer
• Liver Cancer
• Bone Cancer
• Neurological/Musculoskeletal/Cardiovascular Indications

Computer Aided Detection Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Computer Aided Detection Market

In each of these regions, there has been growing activity in the computer-aided detection (CAD) market due to technological enhancements, regulatory changes, and increased healthcare funding. These factors are increasing the acceptance of CAD technologies for early disease detection and improving diagnostic accuracy, benefiting patients worldwide.

• United States: In the United States, CAD is advancing rapidly, especially due to developments in AI and ML integrated into CAD systems. Recent initiatives involve new CAD software applications seeking FDA approval and improvements in image analysis algorithms, enabling earlier diagnosis of diseases like cancer and heart conditions. Furthermore, major health insurance providers are financing CAD systems to optimize diagnostic process workflows.
• China: With improvements in health infrastructure and technology, there is also an increased adoption of CAD systems in China. Other advancements include the installation of AI-based CAD systems in leading hospitals and research centers. This trend aligns with government policy aimed at enhancing diagnostics and public health financing to counter the growing prevalence of non-communicable diseases and ensure quality healthcare services.
• Germany: In Germany, the use of CAD systems in clinical settings is on the rise due to improvements in imaging technology and political will. The CAD system was recently updated by merging it with advanced imaging modalities such as MRI and CT scans. German commitment to precision medicine and sustained research and development efforts also contribute to the growth of the CAD market in the region.
• India: The Indian CAD market is driven by growing medical needs and technological evolution. Recent developments include the launch of CAD systems tailored for the Indian market that are affordable. Stronger government programs and contributions from the private sector are extending the application of CAD systems in the country, with the major objective of early detection of patients' diseases and improving the effectiveness of the CAD systems.
• Japan: The CAD market in Japan is witnessing notable developments with improvements in image processing technologies and increased partnerships between healthcare providers and technology companies. The application of CAD systems in Japan is favorable, supported by government programs aimed at enhancing diagnostic quality and patient care. The region is experiencing innovation in new and advanced CAD systems due to the influence of artificial intelligence and machine learning.

Features of the Global Computer Aided Detection Market

Market Size Estimates: Computer aided detection market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Computer aided detection market size by indication, application, and region in terms of value ($B).

Regional Analysis: Computer aided detection market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different indications, applications, and regions for the computer aided detection market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the computer aided detection market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the computer aided detection market by indication (x-ray imaging, computed tomography, ultrasound imaging, magnetic resonance, and nuclear medicine imaging), application (tuberculosis, breast cancer, lung cancer, colon cancer, prostate cancer, liver cancer, bone cancer, and neurological/musculoskeletal/cardiovascular indications), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Computer Aided Detection Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Computer Aided Detection Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Computer Aided Detection Market by Indication
  • 3.3.1: X-Ray Imaging
  • 3.3.2: Computed Tomography
  • 3.3.3: Ultrasound Imaging
  • 3.3.4: Magnetic Resonance
  • 3.3.5: Nuclear Medicine Imaging
• 3.4: Global Computer Aided Detection Market by Application
  • 3.4.1: Tuberculosis
  • 3.4.2: Breast Cancer
  • 3.4.3: Lung Cancer
  • 3.4.4: Colon Cancer
  • 3.4.5: Prostate Cancer
  • 3.4.6: Liver Cancer
  • 3.4.7: Bone Cancer
  • 3.4.8: Neurological/Musculoskeletal/Cardiovascular Indications

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Computer Aided Detection Market by Region
• 4.2: North American Computer Aided Detection Market
  • 4.2.1: North American Computer Aided Detection Market by Indication: X-Ray Imaging, Computed Tomography, Ultrasound Imaging, Magnetic Resonance, and Nuclear Medicine Imaging
  • 4.2.2: North American Computer Aided Detection Market by Application: Tuberculosis, Breast Cancer, Lung Cancer, Colon Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, and Neurological/Musculoskeletal/Cardiovascular Indications
• 4.3: European Computer Aided Detection Market
  • 4.3.1: European Computer Aided Detection Market by Indication: X-Ray Imaging, Computed Tomography, Ultrasound Imaging, Magnetic Resonance, and Nuclear Medicine Imaging
  • 4.3.2: European Computer Aided Detection Market by Application: Tuberculosis, Breast Cancer, Lung Cancer, Colon Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, and Neurological/Musculoskeletal/Cardiovascular Indications
• 4.4: APAC Computer Aided Detection Market
  • 4.4.1: APAC Computer Aided Detection Market by Indication: X-Ray Imaging, Computed Tomography, Ultrasound Imaging, Magnetic Resonance, and Nuclear Medicine Imaging
  • 4.4.2: APAC Computer Aided Detection Market by Application: Tuberculosis, Breast Cancer, Lung Cancer, Colon Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, and Neurological/Musculoskeletal/Cardiovascular Indications
• 4.5: ROW Computer Aided Detection Market
  • 4.5.1: ROW Computer Aided Detection Market by Indication: X-Ray Imaging, Computed Tomography, Ultrasound Imaging, Magnetic Resonance, and Nuclear Medicine Imaging
  • 4.5.2: ROW Computer Aided Detection Market by Application: Tuberculosis, Breast Cancer, Lung Cancer, Colon Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, and Neurological/Musculoskeletal/Cardiovascular Indications

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Computer Aided Detection Market by Indication
  • 6.1.2: Growth Opportunities for the Global Computer Aided Detection Market by Application
  • 6.1.3: Growth Opportunities for the Global Computer Aided Detection Market by Region
• 6.2: Emerging Trends in the Global Computer Aided Detection Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Computer Aided Detection Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Computer Aided Detection Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: EDDA Technology
• 7.2: FUJIFILM Holdings Corporation
• 7.3: Hologic
• 7.4: Koninklijke Philips
• 7.5: Siemens
• 7.6: Nano-X Imaging
• 7.7: Canon Medical Systems
• 7.8: General Electric
• 7.9: IBM
• 7.10: Riverain Technologies